SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000886163-22-000069
Filing Date
2022-06-13
Accepted
2022-06-13 08:44:28
Documents
6
Effectiveness Date
2022-06-13

Document Format Files

Seq Description Document Type Size
1 S-8 ligand-formsx8june2022.htm S-8 122237
2 EX-FILING FEES s-8_exhibit107.htm EX-FILING FEES 24771
3 EX-5.1 s-8_exhibit51.htm EX-5.1 11952
4 EX-10.2 s-8_exhibit102.htm EX-10.2 77133
5 EX-23.1 s-8_exhibit231.htm EX-23.1 2450
6 lwheadera.jpg GRAPHIC 54167
  Complete submission text file 0000886163-22-000069.txt   308835
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-265545 | Film No.: 221010780
SIC: 2834 Pharmaceutical Preparations